They report four rare missense variants in SQSTM1 and three variants in VCP. This represented 4.0% of the cohort, and is the first time potential pathogenic variants in SQSTM1 have been observed in IBM patients. This evidence concerns the gene SQSTM1 and inclusion body myositis.